发明名称 |
Nya formuleringar för behandling av TH2 medierade inflamatoriska sjukdomar |
摘要 |
The invention relates to compositions for the treatment of TH2 mediated inflammatory conditions. The compositions are vaccines comprising a non-primate TSLP or fragments thereof to be used as a vaccine to treat humans with excessive mediated inflammatory conditions. For the treatment of TH2 mediate inflammatory conditions in other non-human mammals the TSLP of the species to be vaccinated is being used as antigen. |
申请公布号 |
SE0602550(L) |
申请公布日期 |
2008.05.29 |
申请号 |
SE20060002550 |
申请日期 |
2006.11.28 |
申请人 |
THERAVAC PHARMACEUTICALS AB |
发明人 |
HELLMAN LARS |
分类号 |
|
主分类号 |
|
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|